Close
4

Seqens Seqens

X

Find Zaleplon manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • CAPSULE;ORAL - 10MG
  • CAPSULE;ORAL - 5MG

Looking for 151319-34-5 / Zaleplon API manufacturers, exporters & distributors?

Zaleplon manufacturers, exporters & distributors 1

33

PharmaCompass offers a list of Zaleplon API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zaleplon manufacturer or Zaleplon supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zaleplon manufacturer or Zaleplon supplier.

PharmaCompass also assists you with knowing the Zaleplon API Price utilized in the formulation of products. Zaleplon API Price is not always fixed or binding as the Zaleplon Price is obtained through a variety of data sources. The Zaleplon Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Zaleplon

Synonyms

151319-34-5, Sonata, Cl-284846, Skp-1041, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide, Zal-846

Cas Number

151319-34-5

Unique Ingredient Identifier (UNII)

S62U433RMH

About Zaleplon

Zaleplon is a nonbenzodiazepine from the pyrazolopyrimidine class with hypnotic, sedative, anxiolytic, and muscle relaxant properties. Zaleplon interacts with the gamma-aminobutyric acid (GABA) -A receptor, thereby affecting the chloride channel ionophore complex and potentiating the inhibitory effects of GABA. In addition, zaleplon binds selectively to the brain omega-1 receptor situated on the alpha subunit of the GABA-A/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding.

MolPort-000-883-860 Manufacturers

A MolPort-000-883-860 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-000-883-860, including repackagers and relabelers. The FDA regulates MolPort-000-883-860 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-000-883-860 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MolPort-000-883-860 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

MolPort-000-883-860 Suppliers

A MolPort-000-883-860 supplier is an individual or a company that provides MolPort-000-883-860 active pharmaceutical ingredient (API) or MolPort-000-883-860 finished formulations upon request. The MolPort-000-883-860 suppliers may include MolPort-000-883-860 API manufacturers, exporters, distributors and traders.

click here to find a list of MolPort-000-883-860 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

MolPort-000-883-860 USDMF

A MolPort-000-883-860 DMF (Drug Master File) is a document detailing the whole manufacturing process of MolPort-000-883-860 active pharmaceutical ingredient (API) in detail. Different forms of MolPort-000-883-860 DMFs exist exist since differing nations have different regulations, such as MolPort-000-883-860 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A MolPort-000-883-860 DMF submitted to regulatory agencies in the US is known as a USDMF. MolPort-000-883-860 USDMF includes data on MolPort-000-883-860's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MolPort-000-883-860 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of MolPort-000-883-860 suppliers with USDMF on PharmaCompass.

MolPort-000-883-860 WC

A MolPort-000-883-860 written confirmation (MolPort-000-883-860 WC) is an official document issued by a regulatory agency to a MolPort-000-883-860 manufacturer, verifying that the manufacturing facility of a MolPort-000-883-860 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting MolPort-000-883-860 APIs or MolPort-000-883-860 finished pharmaceutical products to another nation, regulatory agencies frequently require a MolPort-000-883-860 WC (written confirmation) as part of the regulatory process.

click here to find a list of MolPort-000-883-860 suppliers with Written Confirmation (WC) on PharmaCompass.

MolPort-000-883-860 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MolPort-000-883-860 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for MolPort-000-883-860 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture MolPort-000-883-860 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain MolPort-000-883-860 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MolPort-000-883-860 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of MolPort-000-883-860 suppliers with NDC on PharmaCompass.

MolPort-000-883-860 GMP

MolPort-000-883-860 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of MolPort-000-883-860 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MolPort-000-883-860 GMP manufacturer or MolPort-000-883-860 GMP API supplier for your needs.

MolPort-000-883-860 CoA

A MolPort-000-883-860 CoA (Certificate of Analysis) is a formal document that attests to MolPort-000-883-860's compliance with MolPort-000-883-860 specifications and serves as a tool for batch-level quality control.

MolPort-000-883-860 CoA mostly includes findings from lab analyses of a specific batch. For each MolPort-000-883-860 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

MolPort-000-883-860 may be tested according to a variety of international standards, such as European Pharmacopoeia (MolPort-000-883-860 EP), MolPort-000-883-860 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MolPort-000-883-860 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY